Skip to content
2000
Volume 6, Issue 8
  • ISSN: 1570-1808
  • E-ISSN: 1875-628X

Abstract

Checkpoint-1 kinase plays an important role in the G2M cell cycle control, therefore its inhibition by small molecules is of great therapeutic interest in oncology. In this paper, we have reported the virtual screening of an in-house library of 2499 pyranopyrazole derivatives against the ATP-binding site of Chk1 kinase using Glide 5.0 program, which resulted in six hits. All these ligands were docked into the site forming most crucial interactions with Cys87, Glu91 and Leu15 residues. From the observed results these ligands are suggested to be potent inhibitors of Chk1 kinase with sufficient scope for further elaboration.

Loading

Article metrics loading...

/content/journals/lddd/10.2174/157018009789353455
2009-12-01
2025-10-13
Loading full text...

Full text loading...

/content/journals/lddd/10.2174/157018009789353455
Loading

  • Article Type:
    Research Article
Keyword(s): Chk-1; Docking; Drug Design; Glide; Oncology; Pyranopyrazoles
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test